News | November 15, 2006

FDA Clears MR Analysis Software Created at Johns Hopkins

Diagnosoft, Inc. has received FDA approval for its HARP software that assists physicians in the analysis of magnetic resonance (MR) images by providing quantitative measurements and visualization of regional heart function.

Developed at and licensed from Johns Hopkins University, the technology is the first FDA approved software designed for the analysis of tagged MR images.

"Robust image analysis methods applied to so-called "tagged" MR images provide cardiologists and radiologists with a powerful tool for the measurement and visualization of cardiac muscle performance -- that is, regional cardiac function -- at a level that has not been possible before," said Dr. Jerry Prince, PhD, Diagnosoft founder and professor at JHU. "Radiologists have been limited to the visual analysis of MR images in order to detect weaknesses or abnormalities in the heart muscles. With the Diagnosoft HARP software, images can now be automatically analyzed to reveal a quantitative measure of function and these measures can be visualized on a standard map designed to help physicians correlate abnormalities with coronary arteries that could be blocked."

Diagnosoft HARP is now cleared for clinical applications and can be used by radiologists, cardiologists, and pharmaceutical companies in assisting the diagnosis, staging and monitoring heart disease as well as in the development of new therapies. The company begins selling HARP version 1.1 this month.

Drs. Nael Osman and Jerry Prince, both founders of Diagnosoft, developed the HARP algorithm at Johns Hopkins University, where they are both currently on the faculty and experts in medical image analysis. Dr. Matthias Stuber, also a founder and faculty member at JHU, brings additional expertise in MR imaging to the company.

For more information visit www.diagnosoft.com.

Related Content

HeartVista Announces One Click Autonomous MRI Solution
News | Magnetic Resonance Imaging (MRI) | November 25, 2018
HeartVista announced its artificial intelligence (AI)-driven, One-Click Autonomous MRI acquisition software for cardiac...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
Stress Cardiac MRI Shows High Prognostic Value for Suspected Ischemia Patients
News | Magnetic Resonance Imaging (MRI) | September 17, 2018
Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a study of how single-...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
Videos | Magnetic Resonance Imaging (MRI) | August 13, 2018
Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott Whi
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

A cardiac MRI scanner at the Houston Methodist DeBakey Heart and Vascular Center. There is growing concern that gadolinium contrast may cause chronic health problems in some patients.

Feature | Magnetic Resonance Imaging (MRI) | February 28, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Contrast-Free Cardiac MRI May Better Assess Need for Mitral Valve Surgery
News | Magnetic Resonance Imaging (MRI) | February 27, 2018
A new study published in the Journal of the American College of Cardiology confirms non-invasive cardiac magnetic...
The FDA has cleared the Toshiba Vantage Galan 3.0T XGO Edition MRI from Canon Medical Systems.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac ...
Overlay Init